ArticleFrontiers in bioinformatics2026
Agentic AI for trustworthy synthetic microbial genomics: a perspective on generation, validation, and governance.
Article in Frontiers in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic microbial genomic data are becoming increasingly important for benchmarking microbial genome analysis pipelines, simulating rare taxa, evaluating metagenomic workflows, and supporting reproducible computational biology. Recent genomic foundation models demonstrate that biological sequences can be modelled at unprecedented scale, with emerging capacity for genome-level interpretation, generation, and design. However, the scientific value of synthetic microbial genomic data depends not only on whether sequences can be generated, but whether they are biologically plausible, computationally useful, reproducible, and responsibly governed. This Perspective argues that agentic AI can provide the missing orchestration layer for trustworthy synthetic microbial genomics. Rather than treating synthetic data generation as a single model output, agentic workflows can coordinate specialised roles for sequence generation, biological plausibility assessment, taxonomic validation, functional annotation, contamination detection, downstream benchmarking, provenance logging, and governance review. I propose a validation-first agentic framework in which synthetic microbial genomes, plasmids, phages, and metagenomic profiles are iteratively generated, evaluated, revised, and documented before release or downstream use. Such a framework can help transform synthetic microbial genomic data from computational artefacts into auditable scientific infrastructure with explicit validation gates, escalation criteria, and machine-readable provenance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.